Back
Galectin Therapeutics Vs. Phathom Pharmaceuticals Industry Stock Comparison
Sell
14
GALT
Galectin Therapeutics
Last Price:
$1.03
Seasonality Move:
33.46%
Sell
15
PHAT
Phathom Pharmaceuticals
Last Price:
$7.45
Seasonality Move:
-9.47%
Sell
14
Galectin Therapeutics (GALT)
is a Sell
Is Galectin Therapeutics a Buy, Sell or Hold?
-
The current Galectin Therapeutics [GALT] share price is $1.03. The Score for GALT is 14, which is 72% below its historic median score of 50, and infers higher risk than normal.
-
GALT is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
15
Phathom Pharmaceuticals (PHAT)
is a Sell
Is Phathom Pharmaceuticals a Buy, Sell or Hold?
-
The current Phathom Pharmaceuticals [PHAT] share price is $7.45. The Score for PHAT is 15, which is 70% below its historic median score of 50, and infers higher risk than normal.
-
PHAT is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
GALT Stock Price Chart
What is Galectin Therapeutics's stock price today?
-
The Galectin Therapeutics share price today is $1.03Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GALT is experiencing slight selling pressure.
PHAT Stock Price Chart
What is Phathom Pharmaceuticals's stock price today?
-
The Phathom Pharmaceuticals share price today is $7.45Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PHAT is experiencing selling pressure, which indicates risk of future bearish movement.
GALT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.25 | Sell |
Relative Strength Index (14 RSI): | 20.76 | Sell |
Chaikin Money Flow: | -1963460 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.91 - 2.81) | Sell |
Bollinger Bands (100): | (2.2 - 2.82) | Sell |
PHAT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.16 | Sell |
Relative Strength Index (14 RSI): | 29.68 | Sell |
Chaikin Money Flow: | -1800545 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (8.14 - 9.2) | Sell |
Bollinger Bands (100): | (10.05 - 17.69) | Sell |
GALT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.94 | Sell |
20-day SMA: | 2.26 | Sell |
50-day SMA: | 2.51 | Sell |
200-day SMA: | 2.64 | Sell |
8-day EMA: | 1.86 | Sell |
20-day EMA: | 2.15 | Sell |
50-day EMA: | 2.4 | Sell |
200-day EMA: | 2.46 | Sell |
PHAT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 8.01 | Sell |
20-day SMA: | 8.58 | Sell |
50-day SMA: | 12.23 | Sell |
200-day SMA: | 12.1 | Sell |
8-day EMA: | 8.04 | Sell |
20-day EMA: | 8.9 | Sell |
50-day EMA: | 11.14 | Sell |
200-day EMA: | 12.16 | Sell |
Galectin Therapeutics Earnings Growth & GALT Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Phathom Pharmaceuticals Earnings Growth & PHAT Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.64 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.94 per share, and an increase next year of $1.13 per share.
Galectin Therapeutics Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Phathom Pharmaceuticals Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |